Medical Devices Australia

Australia Digital PCR Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

Australia Digital PCR Market Industry Trends and Forecast to 2034: Segmented by (Product, Application, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Australia · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $9.8 Mn Placeholder estimate
Estimate 2025 $11.1 Mn 1.3% of the global market
Projected 2034 $34.0 Mn 205.2% Adds $22.9 Mn over 9 forecast years
CAGR 2025–2034 13.2% Faster than 71% of 173 Medical Devices markets here
Key players 5
  • Australia is 1.27% of the global market.
  • In APAC, the largest is China at $66.9 Mn.
  • Fastest growing: India at 15% a year.
  • Australia ranks 4th of 10 by size in APAC.

Market size projection

Australia

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$22.9 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Digital PCR Market market size by year, Australia
YearMarket sizeChange that yearSince 2025
2024 (estimate) $9.8 Mn — —
2025 (base) $11.1 Mn +$1.3 Mn —
2026 (forecast) $12.6 Mn +$1.5 Mn +13.2%
2027 (forecast) $14.3 Mn +$1.7 Mn +28.1%
2028 (forecast) $16.2 Mn +$1.9 Mn +45.1%
2029 (forecast) $18.3 Mn +$2.1 Mn +64.2%
2030 (forecast) $20.7 Mn +$2.4 Mn +85.9%
2031 (forecast) $23.5 Mn +$2.7 Mn +110.4%
2032 (forecast) $26.6 Mn +$3.1 Mn +138.2%
2033 (forecast) $30.1 Mn +$3.5 Mn +169.6%
2034 (forecast) $34.0 Mn +$4.0 Mn +205.2%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $878.1 Mn
  2. North America $422.3 Mn
  3. US $316.5 Mn
  4. APAC $209.2 Mn
  5. Europe $150.8 Mn
  6. Canada $67.2 Mn
  7. China $66.9 Mn
  8. Japan $53.6 Mn
  9. Latin America $38.6 Mn
  10. Middle East $31.6 Mn
  11. Germany $26.7 Mn
  12. Italy $22.1 Mn
  13. France $21.9 Mn
  14. UK $21.3 Mn
  15. Brazil $22.0 Mn
  16. Ecuador $19.5 Mn
  17. Spain $16.3 Mn
  18. India $14.4 Mn
  19. Mexico $13.7 Mn
  20. Saudi Arabia $13.6 Mn
  21. Africa $12.0 Mn
  22. Australia (this report) $11.1 Mn
  23. Russia $9.9 Mn
  24. New Zealand $8.1 Mn
  25. South Africa $6.4 Mn
  26. UAE $4.6 Mn
  27. Egypt $2.6 Mn
  28. Philippines $2.1 Mn
  29. Malaysia $1.5 Mn
  30. Hong Kong $1.4 Mn
  31. Thailand $1.0 Mn
  32. Singapore $0.9 Mn
  33. Kenya $0.6 Mn

Report snapshot

Australia Digital PCR Market Analysis at a glance
Market size, 2025$11.1 Mn placeholder estimate
Forecast, 2034$34.0 Mn placeholder estimate
Growth (CAGR), 2025–203413.2% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct, application and end user (see all)
Key playersBio-Rad Laboratories, Thermo Fisher Scientific Inc., Qiagen N.V., Roche Diagnostics, Stilla Technologies (see all)
Regulator in AustraliaTGASource: Therapeutic Goods Administration. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Australia Digital PCR Market Analysis Executive Summary

Digital PCR counts single DNA molecules very precisely, used for cancer monitoring, gene therapy testing and infection detection.

Key segments of the digital PCR market include product (Instruments, Reagents and Software) and application (Oncology, Infectious Disease and Gene Therapy QC).

Bar chart: Australia Digital PCR market size, 2024–2034, placeholder estimates. $9.8 Mn in 2024, $11.1 Mn in 2025 and $34.0 Mn in 2034, 13.2% CAGR.
Australia Digital PCR market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Australia Digital PCR Market Dynamics

Market Growth Drivers

Demand for earlier and faster diagnosis, growth of testing outside hospitals, new molecular technologies and the shift to preventive care are driving the digital PCR market.

Opportunity

Home testing, connected devices that send results to doctors and multiplex tests that check many conditions at once give the digital PCR market room to grow, especially in emerging markets.

Market Restraints

Pricing pressure, uneven reimbursement for new tests, regulatory approval times and the need for skilled lab staff hold back the digital PCR market.

Competitive Landscape for Digital PCR Market in Australia

The digital PCR market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Digital PCR Market in Australia

Digital PCR in Australia: rules and payment

Medical devices must be included in the Australian Register of Therapeutic Goods (ARTG), run by the Therapeutic Goods Administration (TGA), before they can be supplied.⁠[1] Medicare pays for public hospital care and many doctor visits, and the Pharmaceutical Benefits Scheme (PBS) subsidises listed medicines.⁠[2]

[1] Therapeutic Goods Administration. Checked 14 Nov 2026.

[2] Pharmaceutical Benefits Scheme. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how digital PCR products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Australia.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Digital PCR right now, from free public sources.

Latest research 3,784 papers since 2021 (worldwide)

  1. A Poisson-multinomial model for quantifying gene therapy vector integrity using quadplex digital PCR. PloS one, 2026
  2. Digital PCR Workflow for Prime Editing Quantification and Analysis. Methods in molecular biology (Clifton, N.J.), 2026
  3. MitoTALENs reduce mutant mitochondrial DNA carryover following pronuclear transfer. Cell reports methods, 2026
  4. Targeted liquid biopsy using CEUS to facilitate the release of ctDNA in colorectal liver metastasis. Ultrasonics, 2026
  5. Photo-Programmable Temporal Uncoupling Enables One-Pot Isothermal Enrichment and Detection of Low-Abundance Single-Nucleotide Variants. Analytical chemistry, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Digital PCR in context

Australia compared

  • Health spending per person: 6,980 US$ per person (2023). World: 1,317 US$ per person (2023). Highest of the 15 countries we cover in APAC.[1]
  • Doctors: 4.09 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). Highest of the 15 countries we cover in APAC.[2]
  • People aged 65 and over: 18.1% of people (2025). World: 10.4% of people (2025). 3rd highest of the 16 countries we cover in APAC.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Digital PCR market in Australia?
Placeholder estimate: about $11.1 Mn in 2025, rising to about $34.0 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Digital PCR market in Australia growing?
Placeholder estimate: about 13.2% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Digital PCR market report cover?
The report splits the market by product (Instruments, Reagents, Software), application (Oncology, Infectious Disease, Gene Therapy QC, Prenatal Testing) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Digital PCR market?
Key players include Bio-Rad Laboratories, Thermo Fisher Scientific Inc., Qiagen N.V., Roche Diagnostics and Stilla Technologies.
What is driving the Digital PCR market?
Demand for earlier and faster diagnosis, growth of testing outside hospitals, new molecular technologies and the shift to preventive care are driving the digital PCR market.
Who regulates Digital PCR in Australia?
Medical devices must be included in the Australian Register of Therapeutic Goods (ARTG), run by the Therapeutic Goods Administration (TGA), before they can be supplied. Source: Therapeutic Goods Administration. Checked 14 Nov 2026.
How is healthcare paid for in Australia?
Medicare pays for public hospital care and many doctor visits, and the Pharmaceutical Benefits Scheme (PBS) subsidises listed medicines. Source: Pharmaceutical Benefits Scheme. Checked 14 Nov 2026.
How much research is published on Digital PCR?
PubMed lists 3,784 papers on Digital PCR added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Digital PCR in Australia? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard

From our blog

Dermatology Diagnostics: AI and Skin HealthSkin cancers caused over 1.5 million new cases in 2022. Imaging and AI tools are changing how skin conditions… Molecular Point-of-Care Tests: Lab Accuracy, Clinic SpeedTB killed 1.23 million people in 2024. WHO now recommends rapid molecular tests first, bringing lab-grade… Healthcare In-Vitro Diagnostics: What Comes After COVIDCOVID-19 testing created a huge, short-lived spike. Long-term demand for in-vitro diagnostics now comes from…
Back to Catalogue
Keep exploring

Related Medical Devices reports in Australia

See all
Same topic, other categories

Related on diagnostics and lab testing and genomics

See the topic